US Part D rule "unclear;" Advantage plan options

A consortium of US advocacy groups, including the National Senior Citizens Law Center and Disability Rights Wisconsin, has estimated that over one million Medicare Part D prescription drug beneficiaries will pay almost the full price of branded medicines if they opt for them when a generic version is available. Although the practice is similar to one operated by employment-based insurance, the campaigners insist that the provision to charge patients extra is not clearly expressed by the federal Centers for Medicare and Medicaid Services (CMS) or the insurers that impose such a rule.